Your browser doesn't support javascript.
loading
Prognostic Factors Related to Clinical Response in 210 Knees Treated by Platelet-Rich Plasma for Osteoarthritis.
Chopin, Clément; Geoffroy, Marion; Kanagaratnam, Lukshe; Dorilleau, Claire; Ecarnot, Fiona; Siboni, Renaud; Salmon, Jean-Hugues.
Afiliação
  • Chopin C; Department of Rheumatology, University of Reims Champagne-Ardenne (URCA), Reims University Hospital, 51100 Reims, France.
  • Geoffroy M; Department of Rheumatology, Reims University Hospital, 51100 Reims, France.
  • Kanagaratnam L; Department of Research and Public Health, Reims University Hospital, 45, Rue Cognacq-Jay, 51092 Reims, France.
  • Dorilleau C; Department of Rheumatology, University of Reims Champagne-Ardenne (URCA), Reims University Hospital, 51100 Reims, France.
  • Ecarnot F; EA3920, Department of Cardiology, University of Franche-Comté, 25000 Besançon, France.
  • Siboni R; Department of Orthopaedic Surgery, Reims University Hospitals, 51100 Reims, France.
  • Salmon JH; Department of Rheumatology, University of Reims Champagne-Ardenne (URCA), Reims University Hospital, 51100 Reims, France.
Diagnostics (Basel) ; 13(4)2023 Feb 17.
Article em En | MEDLINE | ID: mdl-36832248
ABSTRACT
Many studies have shown the effectiveness of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis. We aimed to determine the factors associated with good or poor response to PRP injections in knee osteoarthritis. This was a prospective observational study. Patients with knee osteoarthritis were recruited from a university hospital. PRP was injected twice at a one-month interval. Pain was assessed on a visual analog scale (VAS) and function was assessed using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Radiographic stage was collected and defined according to the Kellgren-Lawrence classification. Patients were classified as responders if they met the OMERACT-OARSI criteria at 7 months. We included 210 knees. At 7 months, 43.8% were classified as responders. Total WOMAC and VAS were significantly improved between M0 and M7. Physical therapy and a heel-buttock distance >35 cm were the two criteria associated with poor response at M7 by multivariate analysis. Pain VAS at M7 appeared to be lower in patients with osteoarthritis for less than 24 months. No adverse effects were reported. PRP treatment in knee osteoarthritis appears to be well-tolerated and effective, even in patients who reacted poorly to hyaluronic acid. Response was not associated with radiographic stage.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article